Under Pressure to Choose the Right Pressor in the Neonate - Where is the Evidence?

Saturday, May 4, 2024

2:00 PM – 3:30 PM ET

Location: Metro Toronto Convention Centre: 107

CE: Live CME: 1.5

Selected By: Neonatal

Chair(s)

SF

Stephanie Ford, MD (she/her/hers)

Assistant Professor of Pediatrics, Neonatologist
Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicne
Cleveland, Ohio, United States
Shazia Bhombal, MD

Associate Professor
Children’s Healthcare of Atlanta/Emory University
Atlanta, Georgia, United States

Disclosure(s):

Stephanie Ford, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Shazia Bhombal, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Session

Description: A session reviewing the evidence for the treatment of shock and hypotension in neonates.

Shock to the System: Challenges of Diagnosing Neonatal Shock, Dr. Satyan Lakshminrusimha
-The neonatologist's perspective on the types of shock and taking the diagnosis beyond physical exams and vitals

Getting to the Heart of the Matter: The Role of Systolic and Diastolic Dysfunction in Neonatal Shock, Dr. Shahab Noori
-Important considerations and treatment differences for systolic vs. diastolic heart failure

Fast and Furious or Slow and Steady: Kinetics and Dynamics of Vasoactive Pharmacotherapy, Dr. Danielle Rios
-The pharmacokinetics of inotropes and pressors and the unique obstacles neonatologists face trying to use them

Death to Dopamine? Dr. Audrey Hebert
-The uses of dopamine in the modern-day NICU and the evidence behind it

It's All About the Brains - Cerebral Perfusion in Hypotension, Dr. Shiran Moore
-Cerebral regulation during hypotension and evidence for treatment

TARGET Shock - Targeted Agents Reducing Global hypoperfusion in Extreme preTerms, Dr. Gabriel Altit
-The importance of targeted treatment in the treatment of neonatal hypotension

Learning Objectives:

Understand the difficulties in diagnosing types of neonatal shock
Describe the pertinent pharmacokinetics and difficulties in using vasopressors and inotropes in neonates
Apply recent evidence to the treatment of hypotension in preterm infants

Presentations:

2:00 PM – 2:05 PM ET

introductions
Speaker: Stephanie Ford, MD (she/her/hers) – Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicne
2:05 PM – 2:17 PM ET

Shock to the System: Challenges of Diagnosing Neonatal Shock
Speaker: Satyan Lakshminrusimha, MD FAAP (he/him/his) – UC Davis Children's Hospital
2:17 PM – 2:29 PM ET

Getting to the Heart of the Matter: The Role of Systolic and Diastolic Dysfunction in Neonatal Shock
Speaker: Shahab Noori, MD, MS CBTI – Children's Hospital Los Angeles, University of Southern California
2:29 PM – 2:41 PM ET

Fast and Furious or Slow and Steady: Kinetics and Dynamics of Vasoactive Pharmacotherapy
Speaker: Danielle R. Rios, MD, MS (she/her/hers) – University of Iowa Department of Pediatrics
2:41 PM – 2:53 PM ET

Death to Dopamine?
Speaker: Audrey Hebert, MD, FRCPC (she/her/hers) – CHU de Quebec - Universite Laval
2:53 PM – 3:05 PM ET

It's All About the Brains - Cerebral Perfusion in Hypotension
Speaker: Shiran S. Moore, MD (she/her/hers) – Dana Dwek Children's Hospital, Tel Aviv Medical Center
3:05 PM – 3:17 PM ET

TARGET Shock - Targeted Agents Reducing Global hypoperfusion in Extreme preTerms
Speaker: Gabriel Altit, MDCM, MSc, FRCPC (he/him/his) – McGill University Faculty of Medicine and Health Sciences
3:17 PM – 3:30 PM ET

Question and Answer
Speaker: Shazia Bhombal, MD – Children's Healthcare of Atlanta